NCT03634917View on ClinicalTrials.gov

Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

August 30, 2023

Study Completion Date

May 1, 2024

Conditions
Alcoholism
Interventions
DRUG

Acamprosate Calcium

1 capsule with 666 mg Acamprosate

DRUG

Calcium Carbonate

1 capsule with 1500 mg Calcium Carbonate

DRUG

Placebo

1 Capsule with Placebo (lactose monohydrate, micro crystalline cellulose, magnesium stearate)

DRUG

Placebo lead in

1 Capsule with Placebo (lactose monohydrate, micro crystalline cellulose, magnesium stearate)

Trial Locations (1)

01307

Klinik und Poliklinik für Psychiatrie und Psychotherapie; Technische Universität Dresden, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT03634917 - Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence | Biotech Hunter | Biotech Hunter